Waheed Nadia 4
4 · OCULAR THERAPEUTIX, INC · Filed Jun 4, 2024
Insider Transaction Report
Form 4
Waheed Nadia
Chief Medical Officer
Transactions
- Award
Common Stock
2024-06-01+141,666→ 141,666 total - Award
Stock Option (Right to Buy)
2024-06-01+425,000→ 425,000 totalExercise: $5.70Exp: 2034-05-31→ Common Stock (425,000 underlying)
Footnotes (2)
- [F1]On June 1, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal annual installments, beginning on the date of grant.
- [F2]Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the reporting person's first date of employment and 2.0833% of the shares vesting monthly thereafter.